Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: Results from the Rotterdam Study

2020-04-01

Atherosclerosis , Volume 299 p. 64- 66

Additional Metadata
Keywords	Cardiovascular disease, Dyslipidaemia guidelines, Epidemiology, Evidence, Primary prevention, Statin
Persistent URL	doi.org/10.1016/j.atherosclerosis.2020.02.020, hdl.handle.net/1765/126295
Journal	Atherosclerosis
Organisation	Department of Epidemiology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Pavlovic, J., Kavousi, M., Ikram, A., & Leening, M.J.G. (Maarten J.G.). (2020). Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: Results from the Rotterdam Study. Atherosclerosis, 299, 64–66. doi:10.1016/j.atherosclerosis.2020.02.020

Publication